Skip to main content
Signal8

Smith Bryan E.

SEC insider (Form 3/4/5 filer). CIK 0001748041. General Counsel, Corporate Sec at Eledon Pharmaceuticals, Inc. (ELDN). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 10, 2025. Located in IRVINE, CA.

Companies Smith Bryan E. has filed insider reports for

  • Eledon Pharmaceuticals, Inc. (ELDN): Officer, General Counsel, Corporate Sec
Smith Bryan E. profile photo

Smith Bryan E.

CIK: 0001748041

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Eledon Pharmaceuticals, Inc. logo
ELDN

Eledon Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Eledon Pharmaceuticals, Inc. logo
    ELDN

    Eledon Pharmaceuticals, Inc.

    Jan 10, 2025
    Award

    Stock Option (right to buy)

    Direct
    150.5K shares-
  • Eledon Pharmaceuticals, Inc. logo
    ELDN

    Eledon Pharmaceuticals, Inc.

    Jan 10, 2025
    Award

    Restricted Stock Units

    Direct
    64.5K shares-
  • Eledon Pharmaceuticals, Inc. logo
    ELDN

    Eledon Pharmaceuticals, Inc.

    Nov 21, 2024
    Award

    Stock Option (right to buy)

    Direct
    474.4K shares-

1-3 of 3